Maxim Cuts Jobs As Part of Realignment

Maxim Pharmaceuticals has implemented a plan realigning its resources and corporate objectives, resulting in 12 layoffs. The San Diego-based company said most of the reductions are related to their Ceplene development programs, which are winding down, but do not impact Maxim's core drug development or drug discovery teams, which remain intact. Individuals affected by the realignment are eligible for a severance package that includes pay, benefits continuation and outplacement services.

Yahoo News

(http://news.yahoo.com/news?tmpl=story&u=/sddt/20050208/lo_sddt/maximcutsjobsaspartofrealignment)